FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966515485> ?p ?o ?g. }

• W1966515485 endingPage "1540" @default.
• W1966515485 startingPage "1534" @default.
• W1966515485 abstract "Background Persistence and development of ECG left ventricular hypertrophy (LVH) by Cornell product criteria are associated with an increased risk of atrial fibrillation compared with regression or continued absence of LVH. We postulated that this association might be in part mediated via greater left atrial enlargement (LAE) in patients with new and persistent ECG LVH. Methods and results Baseline and third year ECG LVH and left atrial systolic diameter were examined in 663 patients in the Losartan Intervention For Endpoint reduction in hypertension echocardiographic substudy who were in sinus rhythm at baseline and had no history of atrial fibrillation. Left atrial systolic diameter was measured and considered enlarged if more than 3.8 cm in women or more than 4.2 cm in men. Cornell product LVH above 2440 mm-ms was considered consistent with LVH. After 3 years follow-up, 238 patients (35.9%) had continued absence of Cornell product LVH, 156 (23.5%) had regression of LVH, 236 (35.6%) had persistent LVH and 33 patients (5.0%) developed new ECG LVH. Compared with third year mean left atrial systolic dimension and prevalence of LAE in patients with continued absence of LVH (3.62 ± 0.52 cm, 12.6%), there were step-wise increases in patients with regression of LVH (3.71 ± 0.49 cm, 20.5%), persistence of LVH (3.82 ± 0.57 cm, 32.2%) and development of new ECG LVH (3.91 ± 0.42 cm, 36.4%, both P < 0.001). After controlling for differences in age, sex, baseline SBP, BMI and Sokolow–Lyon voltage, randomized treatment allocation, change in DBP and SBP between baseline and third year and for isovolumic relaxation time and presence of an abnormal mitral E/A ratio at baseline and third year, the odds of having LAE were significantly increased in patients with persistent LVH (odds ratio 1.8, 95% confidence interval 1.1–3.2, P = 0.043) or new LVH (odds ratio 3.1, 95% confidence interval 1.3–7.7, P = 0.016), but not in patients with regression of Cornell product LVH (odds ratio 1.1, 95% confidence interval 0.6–2.0, P = 0.860). Conclusion Persistence or development of new ECG LVH during antihypertensive therapy are associated with an increased risk of LAE after 3-year follow-up, whereas regression of ECG LVH is not associated with an increased risk of LAE. These findings provide insight into a possible mechanism by which changes in ECG LVH are associated with changing risk of developing atrial fibrillation." @default.
• W1966515485 created "2016-06-24" @default.
• W1966515485 creator A5031475597 @default.
• W1966515485 creator A5040609728 @default.
• W1966515485 creator A5044090184 @default.
• W1966515485 creator A5054747839 @default.
• W1966515485 creator A5058664894 @default.
• W1966515485 creator A5072871923 @default.
• W1966515485 creator A5090567122 @default.
• W1966515485 date "2010-07-01" @default.
• W1966515485 modified "2023-10-02" @default.
• W1966515485 title "Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation" @default.
• W1966515485 cites W101667153 @default.
• W1966515485 cites W1560469707 @default.
• W1966515485 cites W159953378 @default.
• W1966515485 cites W1975540296 @default.
• W1966515485 cites W1988604278 @default.
• W1966515485 cites W1990868110 @default.
• W1966515485 cites W1994289044 @default.
• W1966515485 cites W1997088860 @default.
• W1966515485 cites W2040363731 @default.
• W1966515485 cites W2040622813 @default.
• W1966515485 cites W2062997067 @default.
• W1966515485 cites W2064700756 @default.
• W1966515485 cites W2067026685 @default.
• W1966515485 cites W2067232731 @default.
• W1966515485 cites W2069874909 @default.
• W1966515485 cites W2096943878 @default.
• W1966515485 cites W2101099004 @default.
• W1966515485 cites W2106487550 @default.
• W1966515485 cites W2111091292 @default.
• W1966515485 cites W2111995867 @default.
• W1966515485 cites W2113538204 @default.
• W1966515485 cites W2115401827 @default.
• W1966515485 cites W2115750582 @default.
• W1966515485 cites W2117988565 @default.
• W1966515485 cites W2124719424 @default.
• W1966515485 cites W2128006739 @default.
• W1966515485 cites W2133217116 @default.
• W1966515485 cites W2140592517 @default.
• W1966515485 cites W2143045558 @default.
• W1966515485 cites W2147918774 @default.
• W1966515485 cites W2151074096 @default.
• W1966515485 cites W2155573254 @default.
• W1966515485 cites W2157429813 @default.
• W1966515485 cites W2158880436 @default.
• W1966515485 cites W2171083313 @default.
• W1966515485 doi "https://doi.org/10.1097/hjh.0b013e328338c20e" @default.
• W1966515485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20589977" @default.
• W1966515485 hasPublicationYear "2010" @default.
• W1966515485 type Work @default.
• W1966515485 sameAs 1966515485 @default.
• W1966515485 citedByCount "23" @default.
• W1966515485 countsByYear W19665154852012 @default.
• W1966515485 countsByYear W19665154852013 @default.
• W1966515485 countsByYear W19665154852014 @default.
• W1966515485 countsByYear W19665154852015 @default.
• W1966515485 countsByYear W19665154852016 @default.
• W1966515485 countsByYear W19665154852017 @default.
• W1966515485 countsByYear W19665154852018 @default.
• W1966515485 countsByYear W19665154852019 @default.
• W1966515485 countsByYear W19665154852020 @default.
• W1966515485 countsByYear W19665154852022 @default.
• W1966515485 countsByYear W19665154852023 @default.
• W1966515485 crossrefType "journal-article" @default.
• W1966515485 hasAuthorship W1966515485A5031475597 @default.
• W1966515485 hasAuthorship W1966515485A5040609728 @default.
• W1966515485 hasAuthorship W1966515485A5044090184 @default.
• W1966515485 hasAuthorship W1966515485A5054747839 @default.
• W1966515485 hasAuthorship W1966515485A5058664894 @default.
• W1966515485 hasAuthorship W1966515485A5072871923 @default.
• W1966515485 hasAuthorship W1966515485A5090567122 @default.
• W1966515485 hasConcept C126322002 @default.
• W1966515485 hasConcept C164705383 @default.
• W1966515485 hasConcept C2775914520 @default.
• W1966515485 hasConcept C2776002628 @default.
• W1966515485 hasConcept C2777627335 @default.
• W1966515485 hasConcept C2779161974 @default.
• W1966515485 hasConcept C2780288358 @default.
• W1966515485 hasConcept C2908929049 @default.
• W1966515485 hasConcept C71924100 @default.
• W1966515485 hasConcept C84393581 @default.
• W1966515485 hasConceptScore W1966515485C126322002 @default.
• W1966515485 hasConceptScore W1966515485C164705383 @default.
• W1966515485 hasConceptScore W1966515485C2775914520 @default.
• W1966515485 hasConceptScore W1966515485C2776002628 @default.
• W1966515485 hasConceptScore W1966515485C2777627335 @default.
• W1966515485 hasConceptScore W1966515485C2779161974 @default.
• W1966515485 hasConceptScore W1966515485C2780288358 @default.
• W1966515485 hasConceptScore W1966515485C2908929049 @default.
• W1966515485 hasConceptScore W1966515485C71924100 @default.
• W1966515485 hasConceptScore W1966515485C84393581 @default.
• W1966515485 hasIssue "7" @default.
• W1966515485 hasLocation W19665154851 @default.
• W1966515485 hasLocation W19665154852 @default.
• W1966515485 hasOpenAccess W1966515485 @default.
• W1966515485 hasPrimaryLocation W19665154851 @default.
• W1966515485 hasRelatedWork W1965964500 @default.

• next